Live feed
Filing
SCHEDULE 13G/A
SCHEDULE 13G/A0000932471-25-000165·Immunome Inc.
Schedule 13G ownership disclosure
Immunome Inc
Common Stock · CUSIP: 45257U108
Event date: 2024-12-31
- Filing-level shares
- 3,003,438
- Percent of class
- 4.81%
- The Vanguard Group
Shares: 3,003,438 · Class: 4.81%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000932471-25-000165
- Form type
- SCHEDULE 13G/A
- Filer
- Immunome Inc.
- CIK
- CIK 1472012
- Filed
- Jan 30, 2025
- Reporting period
- Dec 31, 2024
- Description
- Schedule 13G beneficial ownership